tazobactam has been researched along with chloroxine in 1 studies
| Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (chloroxine) | Trials (chloroxine) | Recent Studies (post-2010) (chloroxine) |
|---|---|---|---|---|---|
| 1,327 | 153 | 694 | 45 | 0 | 31 |
| Protein | Taxonomy | tazobactam (IC50) | chloroxine (IC50) |
|---|---|---|---|
| kappa-type opioid receptor isoform 1 | Homo sapiens (human) | 4.56 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 3.6 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 7.24 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | 2.4 | |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | 1.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
1 other study(ies) available for tazobactam and chloroxine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |